I agree that this site is using cookies. You can find further informations here.
X
Kanwal, F.
223  results:
Search for persons X
?
1

HTA2 Cost-Effectiveness of a Clinical Care Pathway for the ..:

Xiao, J. ; Haseeb, M. ; Kanwal, F....
Value in Health.  26 (2023)  12 - p. S320 , 2023
Link: https://doi.org/10.1016/..
 
?
2

EPH9 Non-Alcoholic Fatty Liver Disease Awareness in the Uni..:

Chhatwal, J. ; Aaron, A. ; Loomba, R....
Value in Health.  26 (2023)  12 - p. S204 , 2023
Link: https://doi.org/10.1016/..
 
?
3

HP QI Abstract: Improving Helicobacter pylori Testing in Pa..:

Bernica, J. ; Cole, R. ; Flores, A....
Gastroenterology.  159 (2020)  2 - p. e22-e23 , 2020
Link: https://doi.org/10.1053/..
 
?
4

SnO2 Co-doped with Co and Ni: Synthesis, Characterization, ..:

Shaista, R. ; Bilal, M. ; Hussain, S....
Russian Journal of Physical Chemistry A.  93 (2019)  9 - p. 1778-1782 , 2019
Link: https://doi.org/10.1134/..
 
?
5

Effectiveness and utilization of Grazoprevir and Elbasvir i..:

Puenpatom, A. ; Kramer, J. ; Cao, Y....
Journal of Hepatology.  68 (2018)  - p. S270 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Impact of acid-reducing agents on effectiveness of Elbasvir..:

Kramer, J. ; Puenpatom, A. ; Cao, Y....
Journal of Hepatology.  68 (2018)  - p. S274 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Hepatitis C virus re‐treatment in the era of direct‐acting ..:

Chhatwal, J. ; Chen, Q. ; Ayer, T....
Alimentary Pharmacology & Therapeutics.  47 (2018)  7 - p. 1023-1031 , 2018
Link: https://doi.org/10.1111/..
 
?
8

Real‐world effectiveness of elbasvir/grazoprevir In HCV‐inf..:

Kramer, J. R. ; Puenpatom, A. ; Erickson, K. F....
Journal of Viral Hepatitis.  25 (2018)  11 - p. 1270-1279 , 2018
Link: https://doi.org/10.1111/..
 
?
9

Incidence and prevalence of extrahepatic manifestations of ..:

El-Serag, H. ; Christie, I. ; Puenpatom, A....
Journal of Hepatology.  68 (2018)  - p. S310-S311 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Real world experience with elbasvir/grazoprevir in the Vete..:

Kramer, J.R. ; Puenpatom, A. ; Erickson, K....
Journal of Hepatology.  66 (2017)  1 - p. S54-S55 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Barriers to hepatitis C treatment in the era of direct‐acti..:

Lin, M. ; Kramer, J. ; White, D....
Alimentary Pharmacology & Therapeutics.  46 (2017)  10 - p. 992-1000 , 2017
Link: https://doi.org/10.1111/..
 
?
12

Hepatitis C virus‐related complications are increasing in w..:

Kramer, J. R. ; El‐Serag, H. B. ; Taylor, T. J....
Journal of Viral Hepatitis.  24 (2017)  11 - p. 955-965 , 2017
Link: https://doi.org/10.1111/..
 
?
13

Projection of patients who fail treatment in the era of dir..:

Chhatwal, J. ; Chen, Q. ; Ayer, T....
Journal of Hepatology.  66 (2017)  1 - p. S512-S513 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Phase 3 biomarker study for HCC surveillance using AFP, AFP..:

El-Serag, H. ; White, D. ; Tayob, N....
Journal of Hepatology.  66 (2017)  1 - p. S222-S223 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Palliative Care Quality Indicators for Patients with End-St..:

the Palliative Care Cirrhosis Quality Expert Panel ; Walling, A. M. ; Ahluwalia, S. C....
Digestive Diseases and Sciences.  62 (2016)  1 - p. 84-92 , 2016
Link: https://doi.org/10.1007/..
 
1-15